In a very interesting study, Melo and colleagues found that pancreatic cancer cell-derived exosomes were enriched with glypican-1 (GPC1) protein and could act as a potential diagnostic and screening tool to detect early stages of pancreas cancer. Here, GPC1 is linked to pancreatic neoplasm.